Shopping Cart
- Remove All
 
Your shopping cart is currently empty
ERD-308 induces >95% of ER degradation at concentrations as low as 5 nM in both cell lines (DC50 (concentration causing 50% of protein degradation) of 0.17 nM and 0.43 nM in MCF-7 and T47D ER+ cells, respectively).ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $913 | Backorder | |
| 50 mg | $1,650 | Backorder | |
| 100 mg | $2,650 | Backorder | 
| Description | ERD-308 induces >95% of ER degradation at concentrations as low as 5 nM in both cell lines (DC50 (concentration causing 50% of protein degradation) of 0.17 nM and 0.43 nM in MCF-7 and T47D ER+ cells, respectively).ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment.  | 
| Targets&IC50 |  ER (T47D cells):, DC50: 0.17 nM , ER (MCF-7 cells):0.43 nM   | 
| Molecular Weight | 1004.26 | 
| Formula | C55H65N5O9S2 | 
| Cas No. | 2320561-35-9 | 
| Relative Density. | 1.271 g/cm3 (Predicted) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.